📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-01 18:14
709 analysed today
709
Today
133,598
All-time analysed
40,124
Positive
6,284
Negative
79,370
Neutral
7,752
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
41 announcements match the current filters (relevance ≥ 5).
Indo Borax Q1 PAT Surges 59% to ₹16.25 Cr; Highlights ₹246.12 Cr Kronox Acquisition
Indo Borax & Chemicals released its Q1 FY27 investor presentation, reporting a 31.34% YoY rise in revenue to ₹70.36 Cr and a 59.31% YoY surge in PAT to ₹16.25 Cr with EBITDA margins expanding to 28.14%. A major strategic focus is the board-approved acquisition of a 64.26% stake in Kronox Lab Sciences for ₹246.12 Cr, followed by an open offer for up to 25.79%. Kronox brings ₹101 Cr in FY26 revenue, ₹28 Cr PAT, and over 185 specialty chemical products, substantially expanding Indo Borax's scale relative to its ₹232 Cr TTM revenue.
Confidence: HIGH
What changedThe investor presentation outlines strong Q1 FY27 performance and details the strategic takeover of Kronox Lab Sciences for ₹246.12 Cr, alongside the merger of its infrastructure subsidiary.
Why it mattersThe Kronox acquisition represents a transformative expansion (~106% of Indo Borax's TTM revenue of ₹232 Cr and ~64% of its net worth), diversifying its product portfolio into 185+ specialty chemicals.
Q1 FY27 Revenue: ₹70.36 CrQ1 FY27 PAT: ₹16.25 CrKronox Acquisition Cost: ₹246.12 CrAcquisition Cost vs TTM Revenue: ~106%Acquisition Cost vs Net Worth: ~64.1%Boric Acid Capacity: 20,000 MTPA
📅 Short termEarnings call commentary on September 02, 2026, and open offer timelines will be the key operational focus for the market.
📈 Long termIf successfully integrated, the addition of Kronox's high-purity specialty chemicals business can significantly boost consolidated revenues, export presence, and margin profile.
⚠ Risk flags
- M&A execution and post-acquisition integration risks
- Regulatory and open offer approval risks
- Sensitivity to raw material (boron mineral) import prices
Key Highlights
Q1 FY27 revenue rose 31.34% YoY to ₹70.36 Cr; PAT surged 59.31% YoY to ₹16.25 Cr with 28.14% EBITDA margin
Agreed to acquire 64.26% stake (2.38 Cr shares) in Kronox Lab Sciences for an aggregate of ₹246.12 Cr
Announced open offer along with Zenrock Chemicals for up to 95.70 lakh shares (25.79% stake) in Kronox
Kronox profile adds FY26 revenue of ₹101 Cr, PAT of ~₹28 Cr, and 185+ specialty chemical products
Current installed capacity stands at 20,000 MTPA for Boric Acid (~50% domestic market share) and 6,000 MTPA for DOT
👀 What to Watch
Track statutory approvals and closing milestones for the Kronox Lab Sciences acquisition and open offer, as well as integration synergies in upcoming quarterly results.
India Ratings Places Indo Borax's IND BBB+ and IND A2+ Credit Ratings on Watch Negative
Indo Borax & Chemicals Limited announced that India Ratings and Research has placed its bank loan facility ratings on 'Rating Watch with Negative Implications'. The long-term rating remains at IND BBB+ and short-term rating at IND A2+, revised from a 'Stable' outlook previously. While the company operates with negligible debt of Rs 1 Cr against a net worth of Rs 384 Cr, the negative watch flags potential risks being evaluated by the rating agency.
Confidence: HIGH
What changedIndia Ratings moved Indo Borax's bank facility credit ratings from a 'Stable' outlook to 'Rating Watch with Negative Implications'.
Why it mattersAlthough Indo Borax has minimal bank borrowings (Rs 1 Cr debt), a rating watch negative indicates emerging business, financial, or governance risks that could impact creditworthiness and partner terms.
Revised Long-Term Rating: IND BBB+ (Watch Negative)Previous Long-Term Rating: IND BBB+ / StableRevised Short-Term Rating: IND A2+ (Watch Negative)Current Total Debt: Rs 1 Cr
📅 Short termMarket sentiment may turn cautious until the specific rationale and resolution conditions of the rating watch are clarified.
📈 Long termLimited direct borrowing cost impact due to a virtual debt-free balance sheet, but any eventual downgrade may reflect underlying operational or governance headwinds.
⚠ Risk flags
- Potential credit rating downgrade pending resolution of the negative watch
- Significant drop in promoter holding from 50.79% in Dec 2025 to 38.41% in Jun 2026
Key Highlights
Long-term bank facility rating revised from IND BBB+/Stable to IND BBB+/Rating Watch with Negative Implications
Short-term bank facility rating revised to IND A2+/Rating Watch with Negative Implications from IND A2+
Rating action executed by India Ratings and Research Private Limited as of August 31, 2026
Company balance sheet remains virtually debt-free with reported debt of approximately Rs 1 Cr
👀 What to Watch
Track the detailed rating rationale from India Ratings to understand the triggers behind the negative watch, including any operational or governance concerns.
Indo Borax to acquire 64.26% stake in Kronox Lab Sciences for ₹246.12 crore
Indo Borax & Chemicals has signed a Share Purchase Agreement to acquire a controlling 64.26% stake (2,38,44,000 equity shares) in listed speciality chemicals player Kronox Lab Sciences for ₹246.12 crore. The company along with Zenrock Chemicals will also launch an Open Offer for an additional 25.79% stake (95,70,000 shares). Kronox Lab Sciences reported FY26 revenue of approximately ₹101 crore and PAT of around ₹28 crore. The transaction size represents ~106% of Indo Borax's TTM revenue (₹232 crore) and ~64% of its net worth (₹384 crore), marking a transformative expansion.
Confidence: HIGH
What changedIndo Borax is transitioning from a standalone boron chemicals manufacturer to a diversified high-purity speciality chemicals group by taking controlling ownership of Kronox Lab Sciences.
Why it mattersAdds ~₹101 crore in high-margin revenue (FY26 PAT margin ~28%) and over 185 fine chemical products, substantially broadening Indo Borax's portfolio into pharma and biotech applications.
Acquisition consideration: ₹246.12 croreDeal value vs TTM revenue: ~106%Stake acquired via SPA: 64.26%Open Offer stake: 25.79%Target FY26 Revenue: ~INR 101 croreTarget FY26 PAT: ~INR 28 crore
📅 Short termStock likely to react positively to the earnings-accretive buyout; market will watch Open Offer details and cash outflow/financing details over the coming weeks.
📈 Long termTransformational strategic acquisition providing scale, high-margin fine chemical product lines, and export distribution synergy across pharma and biotech verticals.
⚠ Risk flags
- Open Offer acceptance levels and total cash drain on Indo Borax balance sheet
- Post-merger operational integration and retention of key technical personnel from Kronox
Key Highlights
Acquiring 64.26% stake (2,38,44,000 shares) in Kronox Lab Sciences for ₹246.12 crore
Open Offer launched with PAC Zenrock Chemicals for up to 25.79% stake (95,70,000 shares)
Target company Kronox reported ~₹101 crore revenue and ~₹28 crore PAT in FY26
Indicative completion timeline is 3 months from SPA signing date
Kronox promoters retain 9.95% equity and will provide transition support
👀 What to Watch
Track the detailed Open Offer letter of offer for pricing terms, regulatory/SEBI clearances, and funding structure for the ₹246.12 crore acquisition.
Indo Borax to acquire 64.26% controlling stake in Kronox Lab Sciences for ₹246.12 Cr
Indo Borax & Chemicals has approved the acquisition of a 64.26% controlling stake (2.38 crore shares) in listed entity Kronox Lab Sciences Limited from its promoters for ₹246.12 Cr (₹103.22 per share). Consequentially, the company and PAC Zenrock Chemicals will launch a mandatory open offer for up to 25.79% additional equity at ₹157.27 per share. The base transaction value of ₹246.12 Cr represents ~106% of Indo Borax's TTM revenue (₹232 Cr) and ~64% of its net worth (₹384 Cr). Target company Kronox reported a turnover of ₹101.22 Cr in FY26, bringing high-purity specialty fine chemicals manufacturing under Indo Borax's fold.
Confidence: HIGH
What changedIndo Borax has agreed to acquire controlling ownership (64.26%) in listed specialty fine chemicals maker Kronox Lab Sciences, followed by a mandatory 25.79% open offer.
Why it mattersThis is a transformative acquisition that adds ~₹101 Cr in top-line (~43.6% of Indo Borax's TTM revenue) and diversifies the business beyond boron chemistry into high-purity fine chemicals.
SPA Acquisition Value: ₹246,11,77,680.00SPA Stake Acquired: 64.26%SPA Price per Share: ₹103.22Open Offer Price per Share: ₹157.27Target FY26 Turnover: ₹101.22 CrDeal vs TTM Revenue: ~106%
📅 Short termLikely to trigger positive market sentiment due to the scale of inorganic expansion, though cash outflow/financing details for the SPA and open offer will be key focus areas.
📈 Long termSubstantially expands product basket into high-purity specialty chemicals, creating operational synergies and scaling the consolidated revenue base.
⚠ Risk flags
- High cash outlay (~₹246 Cr for SPA + up to ~₹150 Cr for open offer) relative to net worth of ₹384 Cr
- Post-merger integration and operational synergy execution
Key Highlights
Acquiring 2,38,44,000 shares (64.26% stake) in Kronox Lab Sciences at ₹103.22/share (aggregate ₹246.12 Cr)
Mandatory open offer triggered for up to 95,70,000 shares (25.79% stake) at ₹157.27 per share
Target entity Kronox Lab Sciences reported FY26 turnover of ₹101.22 Cr (vs ₹100.19 Cr in FY25)
Acquisition targeted for completion within 3 months of the public announcement
Base deal size of ₹246.12 Cr is ~106% of Indo Borax's TTM revenue (₹232 Cr)
👀 What to Watch
Track the formal public announcement and detailed letter of offer for the open offer, funding mode (cash reserves vs debt), and post-acquisition consolidated margin profile.
Indo Borax to acquire 64.26% stake in Kronox Lab Sciences for ₹246.12 Cr plus Open Offer
Indo Borax & Chemicals has approved the execution of a Share Purchase Agreement to acquire a 64.26% majority stake (2,38,44,000 equity shares) in listed entity Kronox Lab Sciences Limited for ₹246.12 Cr (₹103.22 per share). The acquisition triggers a mandatory open offer for an additional 25.79% stake (95,70,000 shares) at ₹157.27 per share. Kronox Lab Sciences reported a turnover of ₹101.22 Cr in FY26 and manufactures high-purity specialty fine chemicals. The initial SPA transaction value of ₹246.12 Cr represents ~106% of Indo Borax's TTM revenue (₹232 Cr) and ~64% of its net worth (₹384 Cr).
Confidence: HIGH
What changedIndo Borax has signed a binding SPA to acquire controlling interest (64.26%) in Kronox Lab Sciences, expanding into high-purity fine chemicals.
Why it mattersThis transforms Indo Borax's product portfolio from bulk boron chemicals to high-margin specialty fine chemicals, adding ~₹101 Cr in topline to its existing ₹232 Cr TTM revenue base.
SPA Acquisition Cost: ₹246.12 CrAcquisition Stake (SPA): 64.26%Open Offer Stake / Price: 25.79% @ ₹157.27 per shareTarget FY26 Turnover: ₹101.22 CrSPA Deal Value vs TTM Revenue: ~106%SPA Deal Value vs Net Worth: ~64%
📅 Short termStock reaction is likely to be strong given the transformative scale of the buyout, though cash outgo and pricing differences between SPA (₹103.22) and Open Offer (₹157.27) will be closely analyzed.
📈 Long termConsolidating Kronox Lab Sciences will significantly enhance scale, revenue diversification, and entry into pharmaceutical and high-purity chemical end-markets.
⚠ Risk flags
- Substantial cash outflow (₹246 Cr for SPA + potential ~₹150 Cr for Open Offer) vs ₹384 Cr Net Worth
- Integration and execution risk post-takeover
- Open offer pricing at a significant premium to SPA purchase price
Key Highlights
Acquiring 64.26% promoter stake (2,38,44,000 shares) in Kronox Lab Sciences for ₹246.12 Cr (₹103.22 per share)
Mandatory open offer to public shareholders for up to 25.79% stake (95,70,000 shares) at ₹157.27 per share
Kronox Lab Sciences reported annual turnover of ₹101.22 Cr in FY26 (up from ₹100.19 Cr in FY25 and ₹89.86 Cr in FY24)
Transaction to be funded entirely via cash consideration and targeted for completion within 3 months
👀 What to Watch
Track the upcoming Open Offer schedule, funding mode (cash reserves vs debt addition on a debt-free balance sheet), and post-acquisition integration timeline.
₹400 Cr Borrowing Limit: Indo Borax Seeks Shareholder Approval for Strategic Expansion
Indo Borax & Chemicals is seeking shareholder approval to increase its borrowing limit to ₹400 Cr, a significant jump from its current debt of just ₹1 Cr. This proposed limit represents approximately 186% of its TTM revenue (₹215 Cr) and 104% of its current net worth (₹384 Cr). The company intends to use this financial flexibility for capacity expansion, modernization, and new technology investments. The voting period for this special resolution concludes on September 10, 2026.
Confidence: HIGH
What changedThe company is seeking to create a massive ₹400 Cr credit headroom, moving away from its historically conservative, nearly debt-free capital structure.
Why it mattersThis indicates a major strategic shift toward aggressive expansion. If the ₹400 Cr is fully utilized for productive assets, it could significantly scale the company's revenue beyond the current ₹215 Cr level, though it introduces interest cost risks.
Proposed Borrowing Limit: ₹400 CrCurrent Debt: ₹1 CrLimit vs TTM Revenue: ~186%Limit vs Net Worth: ~104%Cut-off Date: August 7, 2026
📅 Short termThe stock may see positive sentiment as the market reacts to the growth signal, though the actual impact depends on the successful passing of the resolution by September 10.
📈 Long termStructurally significant; the expansion could re-rate the business if new capacities achieve economies of scale, but execution and raw material price volatility remain key long-term risks.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk of new capacity
- Interest cost pressure on OPM
- High sensitivity to boron mineral prices
Key Highlights
Proposed borrowing limit increase to ₹400 Cr under Section 180(1)(c) of the Companies Act.
Current debt stands at only ₹1 Cr, indicating a shift toward leveraging the balance sheet for growth.
E-voting period scheduled from August 12, 2026, to September 10, 2026.
Cut-off date for shareholder eligibility to vote was August 7, 2026.
Funds targeted for expanding production capacities and modernizing infrastructure following the Pithampur plant resumption.
👀 What to Watch
Investors should monitor specific capex announcements and the timeline for capacity additions to gauge how effectively the ₹400 Cr headroom will be deployed. Watch for the impact on operating margins as the company transitions from a debt-free model to a leveraged growth model.
59% PAT Growth in Q1 FY27; Board Approves Subsidiary Amalgamation
Indo Borax reported a strong start to FY27 with consolidated operating income rising 31.34% YoY to ₹70.36 Cr. Net profit surged 59.31% to ₹16.25 Cr, significantly outpacing revenue growth due to a 530-basis point expansion in EBITDA margins to 28.1%. The performance was driven by robust demand across steel, glass, and agriculture sectors and improved capacity utilization at its Pithampur plant. Additionally, the Board has approved the merger of its wholly-owned subsidiary, Indoborax Infrastructure Private Ltd, to streamline governance.
Confidence: HIGH
What changedIndo Borax delivered a sharp earnings beat with significant margin expansion and initiated a corporate restructuring to merge its infrastructure subsidiary.
Why it mattersThe results validate the operational turnaround following the Pithampur plant's resumption in late 2025. The margin expansion suggests strong pricing power or efficiency gains, while the merger simplifies the corporate structure.
Q1 FY27 Revenue: ₹70.36 CrRevenue Growth (YoY): 31.34%PAT Growth (YoY): 59.31%EBITDA Margin: 28.1%Q1 Revenue vs TTM Revenue: 32.7%
📅 Short termThe stock is likely to react positively to the substantial margin expansion and profit growth, which exceeds recent quarterly trends.
📈 Long termStructural growth is supported by the niche boron-chemistry focus and debt-free balance sheet; however, long-term margins remain sensitive to global boron mineral price cycles.
⚠ Risk flags
- Raw material price volatility (boron minerals)
- Regulatory risk related to NCLT merger approval
- Concentrated promoter holding (38.4%)
Key Highlights
Net profit increased by 59.31% YoY to ₹16.25 Cr in Q1 FY27.
Operating income grew 31.34% YoY to ₹70.36 Cr, representing ~33% of TTM revenue.
EBITDA margins expanded significantly to 28.1% from 22.8% in the year-ago period.
Quarterly EPS rose to ₹5.07, compared to ₹3.18 in Q1 FY26.
Board approved the amalgamation of Indoborax Infrastructure Private Ltd with the parent company.
👀 What to Watch
Investors should monitor the sustainability of the 28% EBITDA margin, which is significantly higher than the TTM average of 20.6%, and track the NCLT approval timeline for the subsidiary merger.
Indo Borax Q1 FY27 Results: Subsidiary Reports Rs 16.3 Lakhs Profit; Postal Ballot Proposed
Indo Borax & Chemicals Limited has approved its Q1 FY27 financial results for the period ending June 30, 2026. While the full parent P&L was not detailed in the text, its wholly-owned subsidiary, Indoborax Infrastructure, reported a revenue and PAT of Rs 16.3 lakhs for the quarter. The company also announced a forthcoming Postal Ballot to seek shareholder approval for new resolutions. This follows a strong FY26 where the company achieved a TTM revenue of Rs 215 Cr and maintained a healthy 20.6% operating margin.
Confidence: MEDIUM
What changedThe company has finalized its Q1 FY27 financial performance and is initiating a shareholder vote via postal ballot for unspecified resolutions.
Why it mattersQ1 results provide the first look at FY27 performance following the full resumption of the Pithampur plant in late 2025. The infrastructure subsidiary remains a small part of the business, with assets representing only ~3.4% of the group's net worth.
Subsidiary Revenue (Q1): Rs 16.3 lakhsSubsidiary Total Assets: Rs 1318.4 lakhsSubsidiary Assets vs Net Worth: ~3.4%TTM Revenue (FY26): Rs 215.44 Cr
📅 Short termThe stock may see neutral to range-bound movement as the market digests the full Q1 earnings report and awaits the details of the postal ballot.
📈 Long termLong-term value depends on the core boron chemical business and the company's ability to maintain margins despite raw material price volatility.
⚠ Risk flags
- Limited disclosure on the nature of the Postal Ballot resolutions
- High sensitivity to boron mineral prices
Key Highlights
Subsidiary Indoborax Infrastructure reported a Profit After Tax of Rs 16.3 lakhs for Q1 FY27.
Total assets of the infrastructure subsidiary stood at Rs 1318.4 lakhs (Rs 13.18 Cr) as of June 30, 2026.
The Board approved a draft Postal Ballot Notice for seeking shareholder approval on proposed resolutions.
The Board meeting concluded at 1:25 PM IST on August 10, 2026, lasting approximately 1 hour and 40 minutes.
👀 What to Watch
Investors should monitor the full Q1 P&L statement to see if revenue growth continues the trend from Mar 2026 (Rs 63 Cr) and watch for the specific details of the Postal Ballot resolutions once dispatched.
₹40 Dividend Approved: Indo Borax Shareholders Pass All AGM Resolutions
Indo Borax & Chemicals shareholders have approved a total dividend of ₹40 per share for FY26, comprising a ₹10 final dividend and a ₹30 special dividend. This massive payout (4000% of face value) results in a dividend yield of approximately 10.4% based on the current price of ₹384.6. The total estimated payout of ~₹128.4 Cr significantly exceeds the FY26 PAT of ₹50.4 Cr, indicating a distribution of accumulated reserves. All resolutions, including the re-appointment of Director Sunil Malhotra, were passed with over 98% majority.
Confidence: HIGH
What changedShareholders have officially ratified the FY26 financial results and the substantial ₹40 per share dividend payout proposed by the board.
Why it mattersThe high dividend yield (~10.4%) is a significant return of capital to shareholders, though the payout ratio (over 250% of FY26 PAT) suggests a one-time distribution of surplus cash rather than a sustainable annual trend.
Total Dividend per Share: ₹40Dividend Yield: ~10.4%Estimated Payout vs FY26 PAT: ~254%Total Shares Outstanding: 3,20,90,000Record Date: 21-07-2026
📅 Short termThe stock may see positive sentiment as the high dividend is now officially approved and the payment process begins.
📈 Long termWhile the dividend is high, long-term value depends on the core chemical business growth (15-20% expected) and the operational efficiency of the Pithampur plant.
⚠ Risk flags
- Dividend payout exceeds annual profits, reducing cash reserves for future growth
- High sensitivity to boron mineral pricing which impacts margins
Key Highlights
Approved a total dividend of ₹40 per share, including a ₹30 special dividend and ₹10 final dividend
Dividend resolution passed with 98.07% votes in favor from 1,92,14,736 total votes polled
Total shareholder turnout for the meeting was 59.88% of the 3,20,90,000 outstanding shares
FY26 PAT stood at ₹50.41 Cr, while the total dividend payout is estimated at ~₹128.4 Cr
Ratified the remuneration of Cost Auditors for the financial year ending March 31, 2027
👀 What to Watch
Investors should track the dividend payment date and monitor how the substantial cash outflow affects the company's liquidity for future expansions at the Pithampur plant.
₹40 Dividend Approved at 45th AGM; Registered Office Shifting to Nariman Point
Indo Borax & Chemicals Limited held its 45th AGM on July 28, 2026, where shareholders approved a substantial total dividend of ₹40 per share for FY26. This payout includes a ₹10 final dividend and a ₹30 special dividend, representing a ~10.1% yield on the current market price of ₹395.6. Additionally, the company is shifting its registered office to Nariman Point, Mumbai, effective August 1, 2026. Management addressed queries from 13 speaker shareholders regarding business operations and the Pithampur plant, which resumed in late 2025.
Confidence: HIGH
What changedShareholders formally approved a high-payout dividend structure and the relocation of the corporate registered office.
Why it mattersThe ₹30 special dividend indicates strong cash generation and a commitment to returning capital to shareholders, supported by a debt-free balance sheet. The office relocation to a primary business district may improve corporate accessibility.
Total Dividend per Share: ₹40Dividend Yield (Approx): 10.1%Special Dividend Component: ₹30Face Value: ₹1Speaker Shareholders: 13
📅 Short termThe stock is likely to react positively to the confirmation of the ₹40 dividend, which is significant relative to the current share price.
📈 Long termThe company's focus remains on its niche boron chemistry business; long-term value depends on managing raw material price volatility and sustaining the 20%+ operating margins.
⚠ Risk flags
- Raw material costs represent over 50% of revenue, making margins sensitive to boron mineral prices.
Key Highlights
Approved a total dividend of ₹40 per share (4000% of ₹1 face value), including a ₹30 special dividend.
Registered office shifting to Nariman Point, Mumbai, effective August 1, 2026.
Total of 75 shareholders attended the meeting conducted via Video Conferencing.
Management responded to queries from 13 registered speaker shareholders during the proceedings.
Ratified the remuneration of Cost Auditors for the financial year ending March 31, 2027.
👀 What to Watch
Investors should note the high dividend yield and monitor the upcoming record date for the ₹40 payout. Watch for Q2 FY27 results to see if the Pithampur plant's resumed operations continue to drive the 15-20% expected growth rate.
IND BBB+ Rating Assigned; Rs 90 Cr Capex Planned for FY27-28
India Ratings has assigned a first-time 'IND BBB+'/Stable rating to Indo Borax's proposed Rs 60 Cr bank facilities. The company maintains a dominant 50% market share in the domestic steel/refractory boric acid segment, with FY26 revenue growing to Rs 215.5 Cr. A significant expansion is planned with a Rs 90 Cr capex (~42% of TTM revenue) over FY27-28 to add 10,000 MT of boric acid capacity. However, a critical risk is noted as 100% of the promoter's 30.8% stake is pledged against a Rs 255 Cr debt.
Confidence: HIGH
What changedIndo Borax has received its first formal credit rating from India Ratings and disclosed plans for a major capacity expansion alongside a significant promoter-level debt and pledge situation.
Why it mattersThe rating validates the company's strong market position and debt-free balance sheet, but the disclosure of the 100% promoter pledge and the large capex plan relative to revenue are material for valuation and risk assessment.
Credit Rating: IND BBB+/StableProposed Bank Facility: Rs 60 CrPlanned Capex (FY27-28): Rs 90 CrCapex vs TTM Revenue: ~42%Promoter Pledge: 100%Promoter-level Debt: Rs 255 Cr
📅 Short termThe assignment of an investment-grade rating is positive, but the market may react cautiously to the 100% promoter pledge disclosure.
📈 Long termThe planned 10,000 MT boric acid expansion (commencing FY29) could significantly re-rate the business if executed successfully, provided the promoter-level debt does not lead to a change in control.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- 100% promoter shareholding pledge
- 100% import dependence for key raw materials
- High product concentration in boric acid
- Inventory-driven working capital cycle
Key Highlights
Assigned 'IND BBB+'/Stable rating for proposed Rs 60 Cr bank loan facilities.
Planned capex of Rs 90 Cr for FY27-FY28, representing approximately 42% of TTM revenue.
100% of promoter shareholding is pledged to secure a Rs 255 Cr debt (Zenrock acquisition).
Boric acid sales volumes increased to 15,365 MT in FY26 from 14,296 MT in FY25.
EBITDA per tonne moderated to Rs 26,130 in FY26 from Rs 30,680 in FY25 due to higher raw material costs.
👀 What to Watch
Investors should monitor the execution of the Rs 90 Cr capacity expansion and track the promoter pledge status, as the 100% pledge on a Rs 255 Cr debt is a significant structural risk despite the company's strong operational performance.
₹40 Dividend: Indo Borax Issues TDS Guidelines for Final and Special Dividend Payouts
Indo Borax & Chemicals Limited has issued a detailed communication regarding Tax Deduction at Source (TDS) for its recommended dividend of ₹40 per share for FY 2025-26. The payout consists of a ₹10 final dividend and a ₹30 special dividend, representing a significant yield of approximately 8.7% based on the current price of ₹461. Shareholders must submit relevant tax documents by July 20, 2026, to ensure appropriate tax treatment. The dividend is subject to approval at the Annual General Meeting scheduled for July 28, 2026.
Confidence: HIGH
What changedThe company has initiated the formal process for tax withholding and shareholder communication following the board's recommendation of a substantial dividend payout.
Why it mattersThe ₹40 dividend is a major cash return to shareholders, reflecting the company's strong balance sheet (negligible debt) and recent operational recovery at its Pithampur plant.
Total Dividend per Share: ₹40Dividend Yield (approx): 8.68%Special Dividend Component: ₹30Document Submission Deadline: July 20, 2026AGM Date: July 28, 2026
📅 Short termThe stock may see continued interest due to the high dividend yield as the record date and AGM approach.
📈 Long termWhile the dividend is a positive sign of cash flow, long-term value depends on the sustained 15-20% growth target and managing boron mineral price volatility.
⚠ Risk flags
- Higher TDS (20%) if PAN is not updated
- Raw material cost sensitivity (boron minerals)
Key Highlights
Total dividend recommended is ₹40 per equity share of face value ₹1 each.
Dividend comprises a ₹10 final dividend and a ₹30 special dividend.
TDS of 10% will be deducted for resident individuals if the total dividend exceeds ₹10,000.
Deadline for submitting tax-related documents to the RTA is July 20, 2026.
Annual General Meeting (AGM) for final approval is scheduled for July 28, 2026.
👀 What to Watch
Shareholders should ensure their PAN is correctly updated with their DP or RTA and submit Form 15G/15H or other tax-exempt declarations via the provided link by July 20 to avoid a 20% TDS rate.
July 21 Record Date set for Final and Special Dividend for FY 2025-26
Indo Borax & Chemicals has fixed July 21, 2026, as the record date for determining shareholder eligibility for both a Final Dividend and a Special Dividend for FY 2025-26. The company's books will remain closed from July 22 to July 28, 2026, for the 45th Annual General Meeting. This payout follows a year where the company generated a TTM PAT of ₹50 Cr and realized ₹9.35 Cr from non-core asset sales, likely supporting the 'Special' dividend component.
Confidence: HIGH
What changedThe company has formalized the timeline for its annual shareholder meeting and the distribution of dividends for the previous financial year.
Why it mattersThe inclusion of a 'Special Dividend' suggests management is returning excess cash to shareholders, potentially linked to the ₹9.35 Cr realized from selling office assets earlier in the year.
Record Date: July 21, 2026Book Closure Start: July 22, 2026Book Closure End: July 28, 2026TTM PAT: ₹50 CrAsset Sale Realization: ₹9.35 Cr
📅 Short termThe stock may experience mild positive sentiment and volume as the record date approaches, typical for dividend-paying small caps.
📈 Long termLimited structural impact; the dividend reflects a healthy balance sheet with negligible debt (₹1 Cr) and consistent cash generation.
⚠ Risk flags
- Dividend amount per share not yet disclosed
- Significant promoter stake reduction from 50.8% to 30.8% in the March 2026 quarter
Key Highlights
Record date for dividend eligibility is fixed for July 21, 2026
Book closure period scheduled from July 22, 2026, to July 28, 2026
Dual dividend payout announced: both a Final and a Special Dividend for FY 2025-26
45th Annual General Meeting to be held during the book closure period
👀 What to Watch
Investors seeking the dividend must hold shares by the close of business on July 21, 2026. Watch for the specific dividend per share (DPS) amount to be confirmed at the AGM.
July 21, 2026 Set as Record Date for Final and Special Dividend
Indo Borax & Chemicals has fixed July 21, 2026, as the record date for determining shareholder eligibility for both a Final and a Special Dividend for FY 2025-26. The payout is subject to approval at the company's 45th Annual General Meeting (AGM). With a TTM PAT of Rs 50 Cr and a debt-free balance sheet (D/E 0.00), the company is utilizing its cash reserves to reward shareholders. This follows a strong year where the stock price appreciated by 72.6%.
Confidence: HIGH
What changedThe company has established the formal timeline for its annual shareholder meeting and the subsequent dividend distribution process.
Why it mattersThe inclusion of a 'Special Dividend' alongside the final dividend indicates a surplus of cash, potentially linked to the recent Rs 9.35 Cr realization from non-core asset sales or strong operational performance.
Record Date: 21-Jul-2026Book Closure Start: 22-Jul-2026Book Closure End: 28-Jul-2026TTM PAT: Rs 50 CrDebt-to-Equity Ratio: 0.00
📅 Short termThe stock may see increased interest leading up to the ex-dividend date (typically one business day before the record date), followed by a price adjustment.
📈 Long termLimited; this is a routine distribution of profits, though it reinforces the company's track record of sharing earnings with minority shareholders.
Key Highlights
Record date for dividend eligibility is fixed as July 21, 2026
Book closure period scheduled from July 22, 2026, to July 28, 2026
Announcement includes both a Final Dividend and a Special Dividend for FY 2025-26
The 45th Annual General Meeting (AGM) will be held during this period to seek shareholder approval
Company maintains a strong financial position with TTM OPM of 20.6% and negligible debt of Rs 1 Cr
👀 What to Watch
Investors should monitor the specific dividend amount (Rs per share) once declared to assess the dividend yield against the current market price of Rs 375.1.
Indo Borax to Pay Rs 40 Dividend; Investing Rs 20 Cr in New 4,000 MTPA Boron Oxide Plant
Indo Borax & Chemicals has announced its 45th AGM for July 28, 2026, to approve a total dividend of Rs 40 per share, which includes a significant Rs 30 special dividend from non-core asset sales. The company reported strong FY26 performance with revenue growing 22.9% to Rs 215.45 Cr and PAT rising 18.3% to Rs 50.27 Cr. A key growth catalyst is the planned Rs 20 Cr investment in a new 4,000 MTPA Boron Oxide facility at Pithampur, aimed at higher-margin products. This follows a leadership transition after Zenrock Chemicals acquired a controlling stake.
Confidence: HIGH
What changedThe company has transitioned to new leadership under Zenrock Chemicals and is pivoting from a pure Boric Acid manufacturer to a diversified Boron chemistry player with a new Rs 20 Cr capex plan.
Why it mattersThe high dividend payout (Rs 40) provides immediate yield, while the expansion into Boron Oxide (4,000 MTPA) targets higher-margin segments, potentially re-rating the stock if execution is successful.
Total Dividend: Rs 40 per shareNew Plant Capex: Rs 20 croreCapex vs Net Worth: 5.2%FY26 Revenue Growth: 22.9%New Capacity: 4,000 MTPARecord Date: July 21, 2026
📅 Short termThe stock is likely to see positive interest leading up to the July 21 record date for the substantial Rs 40 dividend.
📈 Long termThe shift toward specialized boron-based solutions and international expansion in South America/South-East Asia marks a structural growth phase for the company.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Raw material costs represent over 50% of revenue; 10% cost spike can squeeze margins by 500 bps.
- Execution risk associated with the new Pithampur facility.
Key Highlights
Total dividend of Rs 40 per share (4000%) declared, including a Rs 30 special dividend from asset monetization.
Planned investment of Rs 20 crore for a new 4,000 MTPA Boron Oxide facility at Pithampur to move up the value chain.
FY 2025-26 revenue increased by 22.9% to Rs 215.45 crore with a record PAT of Rs 50.27 crore.
Record date for dividend entitlement is fixed as July 21, 2026, with payment starting July 29, 2026.
EBITDA and PAT margins remained robust at approximately 20.5% and 21.8% respectively for FY26.
👀 What to Watch
Investors should track the commissioning timeline of the new Boron Oxide facility and monitor if the new management (Zenrock Chemicals) can maintain the 20%+ operating margins amidst raw material price volatility.
16.89 Lakh ESOPs granted at Re 1 Exercise Price, representing ~5.2% potential dilution
Indo Borax & Chemicals Limited has granted 16,88,950 stock options to eligible employees under its ESOP 2026 plan. Each option is convertible into one equity share at an exercise price of Re 1, which is the face value and represents a significant discount to the current market price of Rs 381.1. This grant represents a potential equity dilution of approximately 5.2% of the company's current share capital. The options will vest over a period of 1 to 5 years, with an exercise period of up to 5 years from the date of vesting.
Confidence: HIGH
What changedThe company has formally granted a specific tranche of 1.69 million options under its new 2026 ESOP scheme, establishing the exercise price and vesting timeline.
Why it mattersWhile ESOPs are a standard tool for talent retention, the deep-discounted exercise price (Re 1 vs market price of ~Rs 381) means the company will recognize a significant non-cash compensation expense, and existing shareholders will face moderate dilution.
Options granted: 16,88,950Exercise Price: Re 1Potential Dilution: ~5.2%Vesting Period: 1 to 5 yearsFace Value: Re 1
📅 Short termThe market is likely to view this as a routine administrative event, though the specific dilution percentage may be noted by institutional investors.
📈 Long termThe ESOPs align employee interests with long-term performance over a 5-year horizon, but will gradually increase the floating stock as options are exercised.
⚠ Risk flags
- Equity dilution of ~5.2%
- Impact on reported PAT due to ESOP accounting charges
- Relatively low promoter holding (30.8%)
Key Highlights
16,88,950 options granted under the Indo Borax & Chemicals Limited Employees Stock Option Plan 2026
Exercise price fixed at Re 1 per share, equal to the face value
Potential equity dilution of ~5.2% based on the estimated 3.21 crore outstanding shares
Vesting schedule ranges from a minimum of 1 year to a maximum of 5 years from the grant date
Exercise period expires 5 years from the date of respective vesting
👀 What to Watch
Investors should monitor the impact on 'Employee Benefit Expenses' in upcoming quarterly P&L statements as the company amortizes the fair value of these options. The ~5.2% dilution is notable for a company with a relatively lower promoter holding of 30.8%.
Indo Borax FY26 PAT Grows 18% to ₹50.27 Cr; Declares Massive ₹40 Total Dividend
Indo Borax reported a strong FY26 with revenue growing 22.9% YoY to ₹215.45 crore and PAT increasing to ₹50.27 crore. The company underwent a significant management shift with Zenrock Chemicals becoming the new promoter and a new leadership team taking charge. Shareholders were rewarded with a massive total dividend of ₹40 per share (4000%), including a ₹30 special dividend funded by the sale of non-core assets. Management has provided a positive outlook with a revenue target of ₹250+ crore for FY27.
Key Highlights
Q4 FY26 PAT surged 41.9% YoY to ₹14.53 crore with PAT margins improving by 250 bps to 21.5%.
Declared a total dividend of ₹40 per share for FY26, including a ₹30 special dividend from non-core asset sales.
Maintains a dominant 50% market share in the Indian Boric Acid market and operates with near-zero debt.
Revenue guidance for FY27 set at ₹250+ crore, driven by capacity debottlenecking and expansion in the DOT segment.
Successful transition to new promoter Zenrock Chemicals and a new leadership team led by CEO Suresh Kalra.
👀 What to Watch
Investors should take note of the significant value unlocking through the special dividend and the new management's aggressive growth targets. Monitor the upcoming CAPEX announcements and the company's ability to scale the high-margin DOT and IP-grade segments.
Indo Borax FY26 PAT Up 18% to ₹50.27 Cr; Announces ₹40 Total Dividend per Share
Indo Borax & Chemicals Limited reported a strong financial performance for FY26, with consolidated revenue growing 22.9% YoY to ₹215.45 Cr and PAT increasing 18.3% to ₹50.27 Cr. The company maintained a healthy EBITDA margin of 20.5% and remains a zero-debt entity with a dominant 50% market share in the domestic Boric Acid market. A major ownership transition was completed in January 2026, where institutional investors led by Zenrock Chemicals acquired a 50.80% controlling stake. To reward shareholders, the board announced a total dividend of ₹40 per share, including a ₹30 special dividend.
Key Highlights
Consolidated FY26 revenue increased 22.9% YoY to ₹215.45 Cr, while Q4FY26 revenue grew 25.7% YoY.
Full-year PAT rose 18.3% to ₹50.27 Cr, with Q4FY26 PAT showing a significant jump of 41.9% YoY to ₹14.53 Cr.
Announced a substantial dividend payout of ₹40 per share (₹10 final + ₹30 special) on a face value of ₹1.
Institutional investors acquired a 50.80% controlling stake in January 2026, signaling a strategic management transition.
Maintained zero-debt status and a strong market position with 20,000 MTPA Boric Acid capacity.
👀 What to Watch
The massive dividend payout and entry of institutional promoters are strong positive catalysts for the stock. Investors should monitor the new leadership's execution of expansion strategies and operational optimizations.
Indo Borax FY26 Revenue Rises 23% to ₹215.45 Cr; Earnings Call Set for June 2
Indo Borax & Chemicals Limited has announced its earnings call for June 2, 2026, following a strong financial performance in FY26. The company reported a 22.9% increase in consolidated operating revenue, reaching ₹215.45 crore compared to ₹175.26 crore in FY25. Consolidated Profit After Tax (PAT) also grew significantly to ₹50.27 crore from ₹42.51 crore in the previous year. The management team, including the MD and CFO, will discuss these results and future outlook during the scheduled call.
Key Highlights
Consolidated Operating Revenue grew 22.9% YoY to ₹215.45 crore in FY26.
Consolidated PAT increased by 18.2% YoY to ₹50.27 crore for the full year.
Earnings conference call scheduled for June 2, 2026, at 4:00 PM IST.
Company maintains a strong market position as a leading manufacturer of boron-based chemicals with 45+ years of expertise.
Management representation includes MD & CEO Suresh Katra and CFO Shashikant Bharuka.
👀 What to Watch
Investors should attend or review the earnings call transcripts to understand the drivers behind the 18% PAT growth and management's guidance on boron chemical demand. The stock remains a watch for those interested in niche chemical manufacturers with consistent profitability.
Indo Borax Declares ₹40 Total Dividend; FY26 Revenue Up 23% YoY to ₹215.45 Cr
Indo Borax & Chemicals Limited reported a strong financial performance for FY26, with revenue from operations growing 23% to ₹215.45 crore. The board recommended a massive total dividend of ₹40 per share, which includes a ₹10 final dividend and a ₹30 special dividend. Profit before tax increased to ₹65.81 crore, supported by an exceptional gain of ₹10.15 crore. Investors should note the ongoing NCLT proceedings regarding a ₹5.09 crore inter-corporate deposit which remains unprovided for.
Key Highlights
Total dividend of ₹40 per share (4000% of face value), including a ₹30 special dividend.
Annual Revenue from Operations increased 23% YoY to ₹215.45 crore from ₹175.26 crore.
Profit Before Tax (PBT) rose to ₹65.81 crore for FY26 compared to ₹57.83 crore in FY25.
Exceptional gain of ₹10.15 crore recorded during the financial year.
Company is pursuing recovery of a ₹5.09 crore inter-corporate deposit through NCLT; no interest is being recognized.
👀 What to Watch
The significant special dividend makes the stock highly attractive for income-seeking investors, while the underlying revenue growth shows business strength. Investors should maintain a watch on the NCLT outcome for the outstanding loan recovery.
